Dr. Amer Mahmood received his MSc from Copenhagen University in the field of Autoimmune Destruction of beta cells in Type 1 diabetic patients. He obtained his PhD in Medical Sciences in the field of Human Embryonic PluripotentStem Cell Research and Bone Biology from the University of Southern Denmark where he successfully differentiated human embryonic stem cells into mesoderm and further in bone, fat and cartilage forming mesenchymal stem cells. He did his Post-Doctoral Fellowship at the Biomedical Research Center, Department of The Molecular Endocrinology & Stem Cell Research Unit (KMEB, University of Southern Denmark); he studied the expression of human DLK-1 a novel regulator of bone mass that mediates estrogen deficiency–induced bone loss in mice.
Dr. Mahmood was Assistant Professor and Principle Investigator in Stem cell research at King Saud University in the Stem Cell Unit Department of Anatomy. In 2017, he was promoted to Associate Professor of Stem cell and Regenerative Medicine. His recent research focus is on the field of Mesenchymal Stem Cells and Regenerative Medicine, particularly in skeletal-bone disorders. Dr. Mahmood has also been working extensively in the field small RNA including micro-RNA and siRNA in addition to Nano-fibrous scaffold for bone-, blood vessel and cartilage regeneration. Additionally, his group is looking at differentiation of iPSCs into different mesodermal lineages. Dr. Mahmood’s group has also initiated the first clinical trials with adult stem cells in Saudi Arabia.